MetaCap

Indaptus Therapeutics Inc. Company Profile

NASDAQ: INDPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.82-0.31 (-9.90%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Indaptus Therapeutics at a glance

Indaptus Therapeutics Inc. (NASDAQ: INDP) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in New York, NY. Indaptus Therapeutics is led by Mr. Junyi Dai and employs about 5 people. At a market capitalization of $433.2 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0001857044, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Indaptus Therapeutics do?

Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.

Business description based on the company's public filings.

Company information

Legal name
Indaptus Therapeutics Inc.
Ticker
NASDAQ: INDP
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Junyi Dai
Employees
5
Headquarters
Three Columbus Circle, New York, NY, United States
Phone
646 427 2727
Market cap
$433.16M
SEC CIK
0001857044
Latest annual report
10-K · Mar 17, 2026

Companies similar to Indaptus Therapeutics

INDP peer companies
CompanyPrice% ChgMarket capCompare
EOLSEvolus Inc.6.52-6.86%$431.55Mvs INDP
AQSTAquestive Therapeutics Inc.3.46-6.61%$434.88Mvs INDP
CAPRCapricor Therapeutics Inc.7.59+0.80%$441.30Mvs INDP
LYELLyell Immunopharma Inc.13.80+1.62%$441.82Mvs INDP
CTMXCytomX Therapeutics Inc.2.03-0.98%$442.55Mvs INDP
ARVNArvinas Inc.6.46-4.15%$423.03Mvs INDP
PRTAProthena Corporation plc8.22-2.14%$422.10Mvs INDP
AMRNAmarin Corporation plc10.57-6.13%$444.39Mvs INDP

Related